Rituximab in combination with CHOP or fludarabine in low-grade lymphoma

被引：79

作者：

Czuczman, MS

Fallon, A

Mohr, A

Stewart, C

Bernstein, ZP

McCarthy, P

Skipper, M

Brown, K

Miller, K

Wentling, D

Klippenstein, D

Loud, P

Rock, MK

Benyunes, M

Grillo-López, AJ

Bernstein, SH

机构：

[1] Roswell Pk Canc Inst, Div Hematol Oncol, Lymphoma Serv, Buffalo, NY 14263 USA

[2] Roswell Pk Canc Inst, Div Bone Marrow Transplantat, Lymphoma Serv, Buffalo, NY 14263 USA

[3] Berlex Labs Inc, Richmond, CA USA

[4] Genentech Inc, San Francisco, CA 94080 USA

[5] IDEC Pharmaceut, San Diego, CA USA

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期

关键词：

D O I：

10.1053/sonc.2002.30152

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：36 / 40

页数：5

共 6 条

[1] Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapy [J].

Czuczman, MS ;

Grillo-López, AJ ;

White, CA ;

Saleh, M ;

Gordon, L ;

LoBuglio, AF ;

Jonas, C ;

Klippenstein, D ;

Dallaire, B ;

Varns, C .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (01) :268-276

[2]

Czuczman MS, 2000, BLOOD, V96, p729A

[3] Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs [J].

Demidem, A ;

Lam, T ;

Alas, S ;

Hariharan, K ;

Hanna, N ;

Bonavida, B .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 1997, 12 (03) :177-186

[4]

Grillo-López AJ, 1999, SEMIN ONCOL, V26, P66

[5] Phase II trial of fludarabine monophosphate as first-line treatment in patients with advanced follicular lymphoma: A multicenter study by the Groupe d'Etude des Lymphomes de l'Adulte [J].

SolalCeligny, P ;

Brice, P ;

Brousse, N ;

Caspard, H ;

Bastion, Y ;

Haioun, C ;

Bosly, A ;

Tilly, H ;

Bordessoule, D ;

Sebban, C ;

Harousseau, JL ;

Morel, P ;

Dupas, B ;

Plassart, F ;

Vasile, N ;

Fort, N ;

Leporrier, M .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (02) :514-519

[6]

XIAO YM, 2000, HEMATOL J S1, V1, P63

← 1 →